Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01152853 | PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer(PF299804-AGC) | completed | Phase 2 | 28 | Seoul National University HospitalOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 |
| clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02347956 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | completed | Phase 1 / Phase 2 | 19 | Yonsei UniversityOTHER | 1 | Nov 16, 2015 | clinicaltrials |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)(GRANITE-1) | completed | Phase 3 | 656 | Novartis PharmaceuticalsINDUSTRY | 22 | Nov 3, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01130337 | A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | completed | Phase 2 | 36 | Hoffmann-La RocheINDUSTRY | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT02562976 | OLGA Stage is More Appropriate in Predicting Early Gastric Cancer | completed | — | 227 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Sep 29, 2015 | clinicaltrials |
| NCT01945177 | RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy | completed | N/A | 600 | Changi General HospitalOTHER | 1 | Aug 26, 2015 | clinicaltrials |
| NCT02089373 | A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric Biopsy | completed | N/A | 30 | Yonsei UniversityOTHER | 1 | Aug 21, 2015 | clinicaltrials |
| NCT02521649 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | completed | Phase 2 | 52 | Cancer Advances Inc.INDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT02518529 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Aug 10, 2015 | clinicaltrials |
| NCT02219529 | Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases(MCE) | completed | Phase 3 | 350 | Changhai HospitalOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT01466569 | An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | AbGenomics B.V Taiwan BranchINDUSTRY | 2 | Jun 23, 2015 | clinicaltrials |
| NCT02159339 | DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma | completed | — | 198 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT00544193 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | completed | Phase 1 | 16 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT02454647 | Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | completed | — | 46 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT01838109 | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | completed | N/A | 174 | Seoul National University HospitalOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02454673 | Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer | completed | — | 121 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer(GC5) | completed | Phase 2 | 12 | Cancer Advances Inc.INDUSTRY | 1 | May 21, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02216110 | Endoscopic Submucosal Dissection Versus Gastrectomy | completed | — | 500 | Soonchunhyang University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00477711 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer(EXTRA) | completed | Phase 2 | 41 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00842491 | Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | completed | Phase 2 | 45 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00718913 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | completed | Phase 2 | 40 | Hellenic Oncology Research GroupOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT02444897 | The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy | completed | Phase 3 | 60 | Keimyung University Dongsan Medical CenterOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00718354 | Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT(GASTRANOX) | completed | Phase 3 | 740 | Thrombosis Research InstituteOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT02235246 | The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study | completed | Phase 4 | 60 | Yonsei UniversityOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00084617 | Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02425930 | The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer | completed | — | 85 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT00226811 | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | completed | Phase 2 | 78 | PfizerINDUSTRY | 7 | Mar 30, 2015 | clinicaltrials |
| NCT00553696 | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | completed | Phase 1 | 27 | PfizerINDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02050659 | Omentectomy in Radical Gastrectomy for Gastric Cancer Trial(OMEGA) | completed | — | 100 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Mar 10, 2015 | clinicaltrials |
| NCT02372747 | Comparison of Delta-Shaped and Billroth II After TLDG(TLDG) | completed | N/A | 78 | The First Hospital of Jilin UniversityOTHER | 0 | Feb 26, 2015 | clinicaltrials |
| NCT02370849 | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | completed | Phase 2 | 2 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00447330 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma(XAGastric) | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Feb 13, 2015 | clinicaltrials |
| NCT01579071 | Efficacy and Safety of CO2 vs Room Air Insufflation During ESD for Gastric Tumor | completed | Phase 4 | 110 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00673673 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT02348229 | Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins(ERASAG) | completed | N/A | 149 | The First Hospital of Jilin UniversityOTHER | 0 | Jan 28, 2015 | clinicaltrials |
| NCT01760070 | Comparison of O-type Hybrid Knife and IT Knife in ESD | completed | N/A | 78 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | completed | Phase 2 | 15 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 16, 2015 | clinicaltrials |
| NCT01614522 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | completed | Phase 2 | 24 | ASLAN PharmaceuticalsOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01544413 | Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer | completed | N/A | 112 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 16, 2014 | clinicaltrials |
| NCT01531452 | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 4, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 20, 2015source: clinicaltrials